INSMED INC (1INSM.MI) Fundamental Analysis & Valuation

BIT:1INSM • US4576693075

Current stock price

127 EUR
0 (0%)
Last:

This 1INSM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1INSM.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1INSM has reported negative net income.
  • 1INSM had a negative operating cash flow in the past year.
  • In the past 5 years 1INSM always reported negative net income.
  • 1INSM had a negative operating cash flow in each of the past 5 years.
1INSM.MI Yearly Net Income VS EBIT VS OCF VS FCF1INSM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200M -400M -600M -800M -1B

1.2 Ratios

  • 1INSM has a Return On Assets of -56.38%. This is in the lower half of the industry: 1INSM underperforms 68.67% of its industry peers.
  • 1INSM has a worse Return On Equity (-172.78%) than 60.24% of its industry peers.
Industry RankSector Rank
ROA -56.38%
ROE -172.78%
ROIC N/A
ROA(3y)-52.62%
ROA(5y)-44.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1INSM.MI Yearly ROA, ROE, ROIC1INSM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

  • With a decent Gross Margin value of 79.73%, 1INSM is doing good in the industry, outperforming 69.88% of the companies in the same industry.
  • 1INSM's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for 1INSM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y1.03%
1INSM.MI Yearly Profit, Operating, Gross Margins1INSM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1INSM.MI Health Analysis

2.1 Basic Checks

  • 1INSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for 1INSM has been increased compared to 1 year ago.
  • Compared to 5 years ago, 1INSM has more shares outstanding
  • Compared to 1 year ago, 1INSM has an improved debt to assets ratio.
1INSM.MI Yearly Shares Outstanding1INSM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
1INSM.MI Yearly Total Debt VS Total Assets1INSM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 8.34 indicates that 1INSM is not in any danger for bankruptcy at the moment.
  • 1INSM's Altman-Z score of 8.34 is amongst the best of the industry. 1INSM outperforms 83.13% of its industry peers.
  • A Debt/Equity ratio of 0.98 indicates that 1INSM is somewhat dependend on debt financing.
  • 1INSM has a Debt to Equity ratio of 0.98. This is comparable to the rest of the industry: 1INSM outperforms 40.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 8.34
ROIC/WACCN/A
WACC8.75%
1INSM.MI Yearly LT Debt VS Equity VS FCF1INSM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

2.3 Liquidity

  • A Current Ratio of 3.83 indicates that 1INSM has no problem at all paying its short term obligations.
  • 1INSM has a better Current ratio (3.83) than 77.11% of its industry peers.
  • 1INSM has a Quick Ratio of 3.54. This indicates that 1INSM is financially healthy and has no problem in meeting its short term obligations.
  • 1INSM has a better Quick ratio (3.54) than 74.70% of its industry peers.
Industry RankSector Rank
Current Ratio 3.83
Quick Ratio 3.54
1INSM.MI Yearly Current Assets VS Current Liabilites1INSM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. 1INSM.MI Growth Analysis

3.1 Past

  • The earnings per share for 1INSM have decreased strongly by -14.67% in the last year.
  • The Revenue has grown by 66.73% in the past year. This is a very strong growth!
  • Measured over the past years, 1INSM shows a very strong growth in Revenue. The Revenue has been growing by 29.83% on average per year.
EPS 1Y (TTM)-14.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)66.73%
Revenue growth 3Y35.2%
Revenue growth 5Y29.83%
Sales Q2Q%152.62%

3.2 Future

  • Based on estimates for the next years, 1INSM will show a very strong growth in Earnings Per Share. The EPS will grow by 29.59% on average per year.
  • The Revenue is expected to grow by 62.80% on average over the next years. This is a very strong growth
EPS Next Y52.31%
EPS Next 2Y39.73%
EPS Next 3Y35.01%
EPS Next 5Y29.59%
Revenue Next Year143.6%
Revenue Next 2Y105.91%
Revenue Next 3Y83.23%
Revenue Next 5Y62.8%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1INSM.MI Yearly Revenue VS Estimates1INSM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B 8B 10B
1INSM.MI Yearly EPS VS Estimates1INSM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

1

4. 1INSM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for 1INSM. In the last year negative earnings were reported.
  • Also next year 1INSM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1INSM.MI Price Earnings VS Forward Price Earnings1INSM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1INSM.MI Per share data1INSM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

  • 1INSM's earnings are expected to grow with 35.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.73%
EPS Next 3Y35.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1INSM.MI Dividend Analysis

5.1 Amount

  • No dividends for 1INSM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1INSM.MI Fundamentals: All Metrics, Ratios and Statistics

INSMED INC

BIT:1INSM (3/3/2026, 7:00:00 PM)

127

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)01-09
Earnings (Next)05-06
Inst Owners101.55%
Inst Owner ChangeN/A
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap27.37B
Revenue(TTM)606.42M
Net Income(TTM)-1.28B
Analysts85.38
Price Target187.68 (47.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.54%
Min EPS beat(2)-28.09%
Max EPS beat(2)-16.99%
EPS beat(4)0
Avg EPS beat(4)-19.6%
Min EPS beat(4)-28.87%
Max EPS beat(4)-4.46%
EPS beat(8)1
Avg EPS beat(8)-15.82%
EPS beat(12)2
Avg EPS beat(12)-15.8%
EPS beat(16)4
Avg EPS beat(16)-12.57%
Revenue beat(2)2
Avg Revenue beat(2)35.81%
Min Revenue beat(2)20.71%
Max Revenue beat(2)50.91%
Revenue beat(4)3
Avg Revenue beat(4)17.97%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)50.91%
Revenue beat(8)4
Avg Revenue beat(8)8.23%
Revenue beat(12)5
Avg Revenue beat(12)5.82%
Revenue beat(16)6
Avg Revenue beat(16)4.28%
PT rev (1m)0.65%
PT rev (3m)N/A
EPS NQ rev (1m)8.58%
EPS NQ rev (3m)30.89%
EPS NY rev (1m)0%
EPS NY rev (3m)23.78%
Revenue NQ rev (1m)20.52%
Revenue NQ rev (3m)69.92%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)29.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 51.57
P/FCF N/A
P/OCF N/A
P/B 42.32
P/tB 61.91
EV/EBITDA N/A
EPS(TTM)-5.55
EYN/A
EPS(NY)-2.65
Fwd EYN/A
FCF(TTM)-3.93
FCFYN/A
OCF(TTM)-3.8
OCFYN/A
SpS2.46
BVpS3
TBVpS2.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -56.38%
ROE -172.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.73%
FCFM N/A
ROA(3y)-52.62%
ROA(5y)-44.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y1.03%
F-Score4
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 169.93%
Cap/Sales 5.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.83
Quick Ratio 3.54
Altman-Z 8.34
F-Score4
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)143.21%
Cap/Depr(5y)111.56%
Cap/Sales(3y)5.25%
Cap/Sales(5y)4.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y52.31%
EPS Next 2Y39.73%
EPS Next 3Y35.01%
EPS Next 5Y29.59%
Revenue 1Y (TTM)66.73%
Revenue growth 3Y35.2%
Revenue growth 5Y29.83%
Sales Q2Q%152.62%
Revenue Next Year143.6%
Revenue Next 2Y105.91%
Revenue Next 3Y83.23%
Revenue Next 5Y62.8%
EBIT growth 1Y-26.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.95%
EBIT Next 3Y38.19%
EBIT Next 5YN/A
FCF growth 1Y-37.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.72%
OCF growth 3YN/A
OCF growth 5YN/A

INSMED INC / 1INSM.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INSMED INC?

ChartMill assigns a fundamental rating of 3 / 10 to 1INSM.MI.


Can you provide the valuation status for INSMED INC?

ChartMill assigns a valuation rating of 1 / 10 to INSMED INC (1INSM.MI). This can be considered as Overvalued.


What is the profitability of 1INSM stock?

INSMED INC (1INSM.MI) has a profitability rating of 1 / 10.